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Abstract: Numerous studies have demonstrated the role of uridine diphosphate (UDP) and its P2Y6 receptor in the in-
flammatory reaction and innate immunity. However, the importance of the P2Y6 receptor in the adaptive immune re-
sponse remains unclear. In this study, we demonstrate that the P2Y6 receptor is functionally expressed in murine bone 
marrow dendritic cells (BMDC). UDP induced a Ca2+ transient in these cells that was decreased in P2Y6-deficient mice. 
UDP also increased the endocytosis of fluorescein isothiocyanate-dextran (FITC-dextran) and amplified the secretion of 
interleukin 12-p70 (IL-12p70) induced by CpG; these responses were abolished in P2Y6-deficient mice. In vivo experi-
ments showed that the serum level of specific IgG2c after immunisation with ovalbumin was decreased in 
P2Y6-deficient mice, while the level of specific IgG1 was unchanged. These data suggest that the P2Y6-mediated effects 
of UDP on myeloid dendritic cells play a role in the in vivo Th1 skewing of the immune response. 
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1. Introduction 
n increasing number of studies have shown 
that extracellular nucleotides and nucleosides 
modulate the inflammatory reaction and the 
immune response by a v ariety of mechanisms[1–3]. 
Adenosine triphosphate (ATP) and other nucleotides 
are now considered as danger signals or Damage As-
sociated Molecular Patterns (DAMPs) that are re-
leased from injured or stressed cells by a variety of 
mechanisms including cell lysis, exocytosis of secre-
tory granules and efflux through channels like con-
nexins and pannexins[4,5]. Extracellular ATP modulates  
cell responses in an autocrine or paracrine way thr-
ough the activation of the P2X receptors, which are 
nucleotide-gated ion channels, or of the G protein- 
coupled P2Y receptors[6,7]. ATP is degraded by ecto-
nucleotidases into adenosine diphosphate (ADP) and 
later, adenosine, that also modulate the immune re-
sponse through the P2Y12 receptor and the A1, A2 and 
A3 receptors, respectively
[1,8].  
Uridine nucleotides are also important and an in-
creasing number of studies have demonstrated the role 
of uridine diphosphate (UDP) and its P2Y6 receptor in 
A 
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the inflammatory reaction and the immune response. 
The P2Y6 receptor plays a role in the activation of 
monocytes/macrophages[9–12], microglial phagocyto-
sis[13,14], secretion of various cytokines and chemoki-
nes from epithelial and other cells[15–21] and activation 
of microvascular endothelial cells during vascular in-
flammation[22]. The role of UDP and P2Y6 receptors in 
adaptive immunity is less clear and apparently more 
complex. UDP has been shown to activate myeloid 
dendritic cells[23,24], but it is unclear if this action is 
mediated by the P2Y6 receptor, since immature den-
dritic cells express the P2Y14 receptor
[25], which is 
also responsive to UDP[26,27]. The P2Y6 receptor is 
also expressed in plasmacytoid dendritic cells, where 
UDP inhibits the production of interferon-α[28,29]. Ex-
pression of the P2Y6 receptor has also been detected 
in activated CD4+ lymphocytes[30,31]. It has been re-
ported that activation of murine T cells by T cell re-
ceptor (TCR) stimulation is inhibited by a P 2Y6 an-
tagonist[32], while a study on P 2Y6-deficient mice 
showed that the absence of P2Y6 receptor on CD4
+ 
cells, but not antigen presenting cells, amplified the 
production of cytokines in a model of allergic pulmo-
nary inflammation[31].   
The aim of the present study was to clarify the roles 
of the P2Y6 receptor in the activation of myeloid den-
dritic cells and their in vivo impact in a model of im-
munisation, using P2Y6-deficient mice previously 
generated in our laboratory[10]. Our results show that 
the P2Y6 receptor controls the biology of dendritic 
cells and that its expression is required for optimal 
IgG2c production in vivo. 
2. Materials and Methods 
2.1 Reagents 
UDP, ionomycin, ovalbumin and fluorescein isothio-
cyanate-dextran (FITC-dextran, 40 kDa) were purch-
ased from Sigma-Aldrich. Fluo-4AM was purchased 
from Invitrogen.  
2.2 Animals 
P2Y6
−/− mice that we previously generated were cro-
ssed with C57BL/6 mice for up to 10 generations[10]. 
All of the mice used in this study were spawned using 
heterozygous parents and housed in a sanitary pro-
tected animal facility.  
2.3 Ethics Statement 
All of the animal studies were authorized by the Ani-
mal Care Use and Review Committee of the Univer-
sité Libre de Bruxelles (CEBEA IBMM protocol 44). 
2.4 Dendritic Cells Generation 
Bone marrow-derived dendritic cells (BMDC) were 
generated as previously described by Inaba et al.[33]. 
Briefly, bone marrow cells obtained from femur and 
tibia were cultured for 7 days in complete medium 
[RPMI 1640 supplemented with 5% FCS (foetal calf 
serum; MultiCell Technologies, Lincoln, RI), 2 mM 
L-glutamine, 100 U/mL penicillin, 100 µg/mL strep-
tomycin and 50 µM 2-mercaptoethanol] supplemented 
with 20 ng /mL GM-CSF (granulocyte-macrophage 
colony-stimulating factor; Invitrogen). Culture me-
dium was partly refreshed on day 3 and 5. 
2.5 Isolation of RNA, Reverse Transcription and 
PCR 
Total RNA was extracted using Tripure reagent (Ro-
che Applied Science, Basel, Switzerland) and quanti-
fied on a NanoDrop 1000 (Thermo Fisher Scientific, 
Waltham, MA). After DNase I treatment (Fermentas, 
Hanover, Germany), RNA was reverse transcribed 
using the Revert Aid H Minus M-MuLV Reverse 
Transcriptase (Fermentas). PCR (29 cycles) were per-
formed using the Qiagen Taq Core Kit. Primer se-
quences used were HPRT: forward 5′-CCTGCTGGA-
TTACATTAAAGCACTG-3′, reverse 5′-GTCAAGG-
GCATATCCAACAACAAAC-3′ and P2Y6: forward 
5′-GGTAGCGCTGGAAGCTAATG-3′, reverse 5′-A-
GGAACACCAAATCTGGCA-3′. 
2.6 [Ca2+]i Measurement 
[Ca2+]i was measured in BMDC as described
[34]. Bri-
efly, freshly isolated BMDC were labelled with the cal-
cium fluorescent dye Fluo-4-AM (5 µM) in 250 µM 
(1,2)-diphenyl-4-[phenylsulfinylethyl]-3,5-pyrazolidin
edione and pluronic acid F-127 (100 µg/mL). Cell 
fluorescence was monitored at 37°C, using a Becton 
Dickinson FACScan Flow Cytometer. Data were analy-
sed with the Winmdi software. Results were expressed 
as a ratio of the maximal response induced by 300 ng/mL 
ionomycin added 2 min after agonist stimulation. 
2.7 Endocytosis 
BMDC were stimulated as indicated below in the com-
plete medium described earlier. FITC-dextran (1 mg/mL) 
and UDP (100µM) were simultaneously added to the 
cell culture and incubated at 37 °C for 30 min. After 3 
Dorothée Cammarata, Abduelhakem Ben Addi, Eva D’Amico, et al. 
   Journal of Medicines Development Sciences (2016)–Volume 2, Issue 1  
washes with cold PBS [phosphate-buffered saline; 
supplemented with 0.1% bovine serum albumine (BSA) 
and 0.1% sodium azide], cells were labelled with phy-
coerythrin conjugated anti-CD11c antibody (eBiosci-
ence) and then analysed using a FC500 flow cytome-
ter (Beckman Coulter). Cells incubated with the probe 
at 4 °C were used as background controls. Trypan blue 
(0.05%) was used to quench extracellular fluorescence. 
Data obtained are mean fluorescence intensity (MFI) 
of CD11c positive cell population. 
2.8 IL-12p70 Measurement  
BMDC were cultured for 24 h in complete medium 
with CpG ODN 1826 (250 ng/mL) with or without 
UDP (100 µM). Cell-free supernatants were harvested 
and IL-12p70 concentration was measured with the 
Ready-Set-Go enzyme linked immunosorbent assay 
kits (eBioscience).  
2.9 Mice Immunization 
Mice were injected subcutaneously at the base of the 
tail with 100 µL of an emulsion (1:1) of incomplete 
Freund’s adjuvant (IFA; Sigma-Aldrich) and ovalbu-
min (100 µg/mice) and bled 14 days later. Serum was 
obtained after centrifugation of clotted blood (2–6 h at 
4°C). Specific anti-ovalbumin immunoglobulins (Ig) 
isotypes G1 and G2c were quantified by ELISA (LO- 
IMEX, Brussels, Belgium). Briefly, 96-well flat-bottom 
plates were coated with ovalbumin (5 µg/mL in PBS) 
overnight at 4°C, to quantify ovalbumin-specific IgG. 
Wells were saturated with 1% BSA in PBS for 1 h at 
room temperature. Serum samples were diluted in PBS/ 
0.5% BSA and incubated for 2 h at 37°C. Specific IgG 
subclasses were detected using horseradish peroxi-
dase-conjugated rat anti-mouse IgG1 or IgG2c anti-
bodies (LO-IMEX, Belgium).  
2.10 Statistical Analysis 
Statistical tests were performed using Sigmat Plot, 
version 13. 
3. Results 
3.1 Functional Expression of the P2Y6 Receptor in 
Dendritic Cells 
We first examined the expression of the P2Y6 receptor 
in BMDC. As shown in Figure 1A, in freshly iso-
lated bone marrow cells, we did not detect any ex-
pression of the P2Y6 mRNA. After 3 and 7 days of 
culture in the presence of GM-CSF (20 ng/mL), we  
 
 
Figure 1. Expression of t he P2Y6 receptor in BMDC. (A) 
RNAs of freshly isolated bone marrow cells (3) or of GM-CSF 
treated adherent bone marrow cells (2: 3 days; 1: 7days) were 
extracted and treated. RT-PCR was performed using specific 
primers for P2Y6 or HPRT. bp: base pairs. (B1) [Ca2+]i meas-
urement in BMDC. Cells were loaded with Fluo-4-AM and 
fluorescence was registered by flow cytometry. After monitor-
ing the basal fluorescence, cells were treated with UDP (100 
µM) or ATP (100 µM) as positive control and fluorescence was 
recorded for 2 min. Then, cells were treated with ionomycin 
(300 nM) for norm alization. The dot plots (time versus FL1 
fluorescence) shown are for each condition of one representa-
tive experiment out of two. (B2) Changes in intracellular cal-
cium concentration in response of UDP or ATP in both geno-
types. Each cell preparation has been tested in duplicates or 
triplicates. Results are shown as box-and-whisker plots of ratios 
of the maximal response measured after ionomycin treatment 
(median: bar into the box; most distant values: bars outside 
the box). *p < 0.03 using Holm-Sidak’s test for multiple com-
parisons. ns: not significant. 
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detected by reverse transcription PCR (RT-PCR) a 
signal at the expected molecular weight (MW), re-
flecting the expression of the P2Y6 mRNA. To check 
the functionality of the P2Y6 receptor, we studied via 
flow cytometry the increase of cytoplasmic calcium 
concentration after UDP stimulation (Figure 1B). In 
wild type (WT) BMDC cells, we observed a marked 
elevation of [Ca2+]i upon UDP (100 µM) stimulation. 
This UDP effect was reduced by 50% in P2Y6
-/- BMDC 
while the response to ATP stimulation was not affected. 
From these data, we can conclude that BMDC express 
a functional P2Y6 receptor. The residual Ca
2+ rise de-
tected in P2Y6-deficient mice might be due to the ac-
tivation of the P2Y14 receptor, a UDP-glucose receptor 
that is known to be sensitive to UDP in rodents[26] and 
to be expressed in human DCs[25].  
3.2 Increased Antigen Uptake by BMDC Under 
P2Y6 Receptor Stimulation 
To characterize the effect of UDP and its receptor on 
endocytosis, we incubated P2Y6
+/+ and P2Y6
−/− BMDC 
in complete medium containing FITC-Dextran known 
to be mainly captured by macropinocytosis[34]. The 
stimulation of wild type BMDC with UDP (100 µM) 
increased cell fluorescence of CD11c+ cells by 2.36 ± 
0.3-fold (mean ± SD of 7 BMDCs preparations ana-
lysed in 4 independent experiments). This UDP effect 
was abolished in P2Y6
−/− BMDC where mean cell 
fluorescence intensity of UDP-treated CD11c+ cells 
was 1.05 ± 0.8-fold of non-treated cells (mean ± SD of 
9 BMDCs preparations). The data of one representa-
tive experiment are shown in Figure 2. 
The involvement of UDP in receptor-mediated en-
docytosis was also investigated using fluorescent oval-
bumin (FITC-OVA) and CpG deoxynucleotide (FITC- 
CpG) as markers[35]. UDP enhanced the uptake of FITC- 
OVA by 1.21 ± 0.08 (mean ± SD of 6 BMDCs prepa-
rations analysed in 3 independent experiments) and 
that of FITC-CpG by 1.19 ± 0.07-fold (mean ± SD of 
5 BMDCs preparations analysed in 2 independent ex-
periments) (data not shown). Again, the stimulatory 
action of UDP was abolished in knockout BMDC 
(data not shown). 
3.3 Increased Production of IL-12p70 by BMDC 
Under P2Y6 Receptor Stimulation 
IL-12p70 plays a key role in the DC-driven Th1 po-
larisation of T cells. UDP alone was unable to increase 
the secretion of IL-12p70 from BMDC (Figure 3). 
However, the CpG-triggered release of this cytokine 
 
 
Figure 2. Effect of P2Y6 activation on FITC-Dextran uptake by 
BMDC. WT and P2Y6
−/− BMDC were incubated with FITC- 
dextran (1 mg/mL) in the presence or absence of UDP (100 µM) 
for 30 m in. Fluorescence of cells was recorded by flow cy-
tometry. Results are shown as box-and-whisker plots of Mean 
of Fluorescence Intensity (MFI) of CD 11c positive cells (me-
dian: bar into the box; most distant values: bars outside 
the box). The data are from one representative experiment out 
of 3. In this experiment, cell preparations from 2 WT mice and 
3 from KO mice have been tested in duplicates or t riplicates.  
***p < 0.001 using the Holm-Sidak test for multiple compari-
sons. ns: not significant. 
 
 
 
Figure 3. Effect of P2Y6 activation on IL-12p70 production by 
BMDC. WT and P2Y6
−/− BMDC were incubated with CpG 
(250 ng/mL) in the presence or absence of UDP (100 µM) for 
24 h. Supernatants were collected for measurement of IL-12p70 
production by ELISA. Results are shown as box-and-whisker 
plots of t he IL-12p70 concentration in the cells’ supernatants 
(median: bar into the box; most distant values: bars outside 
the box). The data are from one representative experiment out 
of 3. In this experiment, cell preparations from 3 WT mice and 
2 from KO mice have been tested in triplicates. *p < 0.04 using 
Dunn’s test for multiple comparisons. ns: not significant. 
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by WT BMDC was amplified by 1.7 ± 0.6-fold (mean 
± SD of 5 BMDC preparations). This UDP effect was 
abolished in P2Y6
−/− BMDC where the production of 
IL-12p70 by UDP+CpG-treated KO BMDC was 0.8 ± 
0.2-fold of the control (mean ± SD of 6 B MDC 
preparations). The data of one representative experi-
ment are shown in Figure 3. 
3.4 Decreased Production of Anti-ovalbumin IgG2c 
in P2Y6−/− Mice 
To study the involvement of the P2Y6 receptor in the 
adaptive immune response in vivo, we subcutaneously 
injected an emulsion of ovalbumin (OVA) in incom-
plete Freund’s adjuvant (IFA) into wild type and P2Y6 
knockout mice. Fourteen days after immunization, we 
determined the concentration of different anti-OVA 
immunoglobulins. As shown in Figure 4A, the serum 
concentration of IgG1 anti-OVA was comparable in 
P2Y6
−/− and P2Y6
+/+ mice, while the anti-OVA IgG2c 
concentration was significantly reduced in P2Y6
−/− 
mice (Figure 4B). These results suggest that the P2Y6 
receptor is involved in a Th1 skewing of the adaptive 
immune response. 
4. Discussion and Conclusion 
UDP has been shown previously to act on myeloid 
DCs, in which it induced a cytosolic Ca2+ transi-
ent[23,24] and chemotaxis[24]. However, it was not pro-
ven that these actions were mediated by the P2Y6 re-
ceptor. They could have involved the P2Y14 receptor 
that is also responsive to UDP[26,27] and is expressed 
on human immature myeloid DCs[25]. Our study with 
P2Y6-deficient mice definitely proves the functional 
expression of P2Y6 in myeloid DCs, resulting in in-
creased antigen endocytosis and IL-12p70 secretion. 
This profile of action is clearly different from that of 
other nucleotide receptors expressed on DCs. In par-
ticular ADP also stimulates antigen endocytosis thr-
ough the P2Y12 receptor
[8], but this action is not asso-
ciated with a stimulation of IL-12p70 secretion. Actu-
ally, ADP decreased IL-12p70 production through its 
degradation into adenosine and activation of A2B ade-
nosine receptors[34,37]. In human myeloid DCs, the P2Y11 
receptor of ATP induces semi-maturation, character-
ised by an increased expression of co-stimulatory mol-
ecules but an inhibition of IL-12p70[38,39]. The P2Y2 
receptor of ATP and UTP is mainly involved in DCs 
chemotaxis[40], whereas the P2X7 receptor of ATP in-
duces the secretion of IL-1β[41,42]. 
The P2Y6-mediated stimulatory effect of UDP on 
antigen endocytosis associated with increased IL-12p70 
secretion is expected to amplify immunisation in vivo 
with a Th1 skewing. This is supported by the observa-
tion of a lower serum level of anti-ovalbumin IgG2c 
in P2Y6-deficient mice immunised against ovalbumin, 
while the level of specific IgG1 was unaffected. In-
deed, a Th2 response is associated with a switching to 
IgG1, while a Th1 response is associated with switch-
ing to IgG2a, or IgG2c in C57BL/6 mice[43].  
We postulate that local injection of antigen in adju-
vant leads to the local release of UDP driving through 
the P2Y6R a Th1 immune response. Therefore, agonists 
 
 
 
Figure 4. Immunoglobulin production in WT P2Y6 and KO P2Y6 mice. Mice were immunised subcutaneously with an emulsion of 
IFA and Ovalbumin. After fourteen days, mice were bled and specific anti-OVA IgG1 (A) or IgG2c (B) were determined in serum by 
ELISA. On the 14 (WT) and 15 (KO) mice immunized, 2 in each group did not respond in terms of IgG2c production (O.D. < 0); they 
have been discarded from the analysis. Data are expressed as mean ± SEM of O.D. from two (A) and three (B) independent experi-
ments. *p < 0.04 using unpaired t-test (WT versus P2Y6 KO are compared at the same dilution). n : number of mice. 
A B ( ) (B) 
Role of the P2Y6 receptor of UDP in the modulation of murine dendritic cell functions and Th1 polarisation... 
  Journal of Medicines Development Sciences (2016)–Volume 2, Issue 1 
 
of this receptor could play the role of adjuvant in case 
of vaccination directed against intracellular pathogens 
which require a Th1 cellular response of the immune 
system. 
In conclusion, our study demonstrates that the P2Y6 
receptor of UDP is functionally expressed on murine 
myeloid dendritic cells, where it mediates a s timula-
tion of antigen endocytosis and IL-12p70 secretion in 
vivo. This last action is expected to result in a Th1 
skewing of the immune response, and this is sup-
ported by the decreased concentration of specific 
IgG2c in P2Y6-deficient mice.  
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